Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sangamo Therapeutics (SGMO) Change in Taxes (2024)

Sangamo Therapeutics (SGMO) has 1 years of Change in Taxes data on record, last reported at $39000.0 in Q4 2024.

  • For Q4 2024, Change in Taxes changed N/A year-over-year to $39000.0; the TTM value through Sep 2025 reached $39000.0, changed N/A, while the annual FY2024 figure was -$556000.0, 114.9% down from the prior year.
  • Change in Taxes reached $39000.0 in Q4 2024 per SGMO's latest filing, down from $537000.0 in the prior quarter.
  • Across five years, Change in Taxes topped out at $1.4 million in Q1 2024 and bottomed at -$2.5 million in Q2 2024.